These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with Oliveira-Santos M; Borges-Rosa J; Silva R; Paixão L; Santo CE; Abrunhosa A; Castelo-Branco M; Slomka PJ; Gonçalves L; Ferreira MJ Atherosclerosis; 2024 Aug; 395():117481. PubMed ID: 38480058 [TBL] [Abstract][Full Text] [Related]
13. Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound. Li L; Li X; Jia Y; Fan J; Wang H; Fan C; Wu L; Si X; Hao X; Wu P; Yan M; Wang R; Hu G; Liu J; Wu Z; Hacker M; Li S Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2181-2189. PubMed ID: 30171271 [TBL] [Abstract][Full Text] [Related]
14. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Joshi NV; Vesey AT; Williams MC; Shah AS; Calvert PA; Craighead FH; Yeoh SE; Wallace W; Salter D; Fletcher AM; van Beek EJ; Flapan AD; Uren NG; Behan MW; Cruden NL; Mills NL; Fox KA; Rudd JH; Dweck MR; Newby DE Lancet; 2014 Feb; 383(9918):705-13. PubMed ID: 24224999 [TBL] [Abstract][Full Text] [Related]
16. Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study. Taglieri N; Nanni C; Ghetti G; Bonfiglioli R; Saia F; Bacchi Reggiani ML; Lima GM; Marco V; Prati F; Fanti S; Rapezzi C Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1878-1887. PubMed ID: 28584972 [TBL] [Abstract][Full Text] [Related]